Robot Assisted Gait Training In Children With Cerebral Palsy
The Effectiveness of Robot Assisted Gait Training In Children With Cerebral Palsy: Randomized Comparative Trial
1 other identifier
interventional
57
1 country
1
Brief Summary
Cerebral Palsy (CP) is considered a neurological disorder caused by a non-progressive brain injury or malformation that occurs while the child's brain is under development. CP primarily affects body movement and muscle coordination. Robot assisted gait training (RAGT) is considered to be a promising approach for improving gait related gross motor function of children and youth with CP. There is weak and inconsistent evidence regarding the use of RAGT for children with gait disorders. Further research is required with increased numbers and with relevant outcome measures to both confirm the effectiveness and clarify training schedules. The aim of this research project is to investigate the effectiveness of robot assisted gait training on improvements of functional gait parameters in children with cerebral palsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2022
CompletedFirst Posted
Study publicly available on registry
September 15, 2022
CompletedStudy Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2023
CompletedFebruary 8, 2024
February 1, 2024
10 months
September 2, 2022
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in GMFM-88 D Item
The Gross Motor Function Measure (GMFM) is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy. GMFM-88 is a measure developed to evaluate the gross motor function changes in CP children. It has five components: lying and rolling, sitting, kneeling and crawling, standing, and walking. D dimension is for Standing abilities. The score of each dimension is expressed as a percentage of the maximum score. There is a scoring system with each item scored as 0, 1, 2, 3, or "not tested". A scoring key of 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed, is used. It takes between 20-25 minutes to be completed.
baseline, 8 weeks, 14 weeks and 20 weeks
Change in GMFM-88 E Item
The Gross Motor Function Measure (GMFM) is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy. GMFM-88 is a measure developed to evaluate the gross motor function changes in CP children. It has five components: lying and rolling, sitting, kneeling and crawling, standing, and walking. E dimension is for Walking, Running \& Jumping abilities. The score of each dimension is expressed as a percentage of the maximum score. There is a scoring system with each item scored as 0, 1, 2, 3, or "not tested". A scoring key of 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed, is used. It takes between 20-25 minutes to be completed.
baseline, 8 weeks, 14 weeks and 20 weeks
Secondary Outcomes (5)
Change in 6 Minute Walk Test
baseline, 8 weeks, 14 weeks and 20 weeks
Change in 10 Meter Walk Test
baseline, 8 weeks, 14 weeks and 20 weeks
Change in Modified Ashworth Scale
baseline, 8 weeks, 14 weeks and 20 weeks
Change in Goal Attainment Scale (GAS)
baseline, 8 weeks, 14 weeks and 20 weeks
Change in Pediatric Quality of Life Inventory (PedsQL) 3.0 Cerebral Palsy Module (Parent Form)
baseline, 8 weeks, 14 weeks and 20 weeks
Study Arms (2)
Robotic assisted gait training (RAGT) + conventional physiotherapy (CPt) group
EXPERIMENTALThis group will receive 15 sessions of robot-assisted gait training (two or three times per week with a maximum of 45 minutes each) and conventional physiotherapy, which is individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.
Conventional physiotherapy (CPt) group
ACTIVE COMPARATORThis group will receive conventional physiotherapy, which is individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.
Interventions
15 sessions of robot-assisted gait training (two times per week with a maximum of 45 minute each).
individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.
Eligibility Criteria
You may qualify if:
- GMFCS Level 2-4
- Bilateral or unilateral spastic CP
- Able to follow instructions and communicate pain or discomfort
- Have a passive range of motion (ROM) of hips and knees within minimum range requirement for robotic assisted training (hip and knee flexion contracture ≤10°, and knee valgus ≤40°)
- Not having participated in another robotic assisted training regime within the previous 6 months
- Able to participate in a minimum of 30 minutes robotic assisted training session
- Able to commit to attendance of two to three times weekly for 15 sessions (to support the primary efficacy analysis)
You may not qualify if:
- Botulinum toxin type A injection within 3 months
- Orthopedic surgery on the lower extremity (muscle surgery within the last 9 months, bone surgery within 12 months)
- Bone fractures, open skin lesions, or circulatory problems
- Vision and hearing impairments that affect participation in robotic assisted training
- Epilepsy resistant to medication
- Cardiopulmonary instability
- Use of a baclofen pump
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University
Ankara, 06530, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Birkan Sonel Tur, Prof
Ankara University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 2, 2022
First Posted
September 15, 2022
Study Start
September 15, 2022
Primary Completion
July 26, 2023
Study Completion
July 26, 2023
Last Updated
February 8, 2024
Record last verified: 2024-02